172 related articles for article (PubMed ID: 16529967)
1. [Ovarian cancers and CA 125 in 2006].
Lambaudie E; Collinet P; Vinatier D
Gynecol Obstet Fertil; 2006 Mar; 34(3):254-7. PubMed ID: 16529967
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
Begum FD; Høgdall E; Kjaer SK; Blaakaer J; Christensen IJ; Christensen L; Høgdall C
Gynecol Oncol; 2009 May; 113(2):221-7. PubMed ID: 19261323
[TBL] [Abstract][Full Text] [Related]
3. [Tumor markers and ovarian cysts].
Vinatier D; Houfflin V; Collinet P
J Gynecol Obstet Biol Reprod (Paris); 2001 Nov; 30(1 Suppl):S34-40. PubMed ID: 11917374
[TBL] [Abstract][Full Text] [Related]
4. [Benign ovarian tumor with ascites and high serum levels of CA125: report of 3 cases].
Li HJ; Shen K; Lang JH; Wu M; Huang HF; Pan LY
Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):147-9. PubMed ID: 12816688
[TBL] [Abstract][Full Text] [Related]
5. [Pelvic tumor, elevated CA 125 level and tuberculosis].
Belletti GA; Millán AE; López A; Yorio MA; Jakob E; Bouchet D; Irico G
Medicina (B Aires); 2005; 65(2):181-2. PubMed ID: 16075819
[No Abstract] [Full Text] [Related]
6. [CA-125 antigen].
Zakrzewska I
Postepy Hig Med Dosw; 2002; 56(1):29-38. PubMed ID: 11987487
[TBL] [Abstract][Full Text] [Related]
7. [CA 125 in the department of internal medicine--a marker of ovarian tumor, thoracic fluid or ascites?].
Kasalický P; Kocián J
Vnitr Lek; 1998 Aug; 44(8):478-80. PubMed ID: 10358454
[TBL] [Abstract][Full Text] [Related]
8. [Tumour markers in epithelial ovarian cancer].
Sparholt MH; Høgdall E; Høgdall CK
Ugeskr Laeger; 2009 Nov; 171(48):3505-9. PubMed ID: 19944049
[TBL] [Abstract][Full Text] [Related]
9. A case of tuberculous peritonitis with elevated CA 125.
Cakir M; Dilber E; Yariş N; Mungan I; Okten A
Turk J Pediatr; 2005; 47(1):100-2. PubMed ID: 15884642
[No Abstract] [Full Text] [Related]
10. [Tumor markers for ovarian cancers].
Aoki D; Kataoka F; Susumu N; Nozawa S
Nihon Rinsho; 2004 Oct; 62 Suppl 10():496-502. PubMed ID: 15535295
[No Abstract] [Full Text] [Related]
11. [CA 125 in epithelial ovarian cancer].
Mogensen O
Ugeskr Laeger; 1998 May; 160(22):3236. PubMed ID: 9621807
[No Abstract] [Full Text] [Related]
12. [Ovarian carcinoma: certain characteristics of evolution, advancement and diagnosis].
Prokopenko PG; Terent'ev AA
Vopr Onkol; 2009; 55(2):143-50. PubMed ID: 19514366
[No Abstract] [Full Text] [Related]
13. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum CA-125 levels: hepatitis or ascites?
Sevinc A; Buyukberber S; Sari R
Gynecol Oncol; 2000 Jan; 76(1):141-2. PubMed ID: 10620461
[No Abstract] [Full Text] [Related]
15. Comparison of the clinical value of CA 19-9 versus CA 125 for the diagnosis of endometriosis.
Kurdoglu Z; Gursoy R; Kurdoglu M; Erdem M; Erdem O; Erdem A
Fertil Steril; 2009 Nov; 92(5):1761-3. PubMed ID: 19631319
[TBL] [Abstract][Full Text] [Related]
16. [Tumor markers and ovarian cancer].
Trifonov I; Todorova M
Akush Ginekol (Sofiia); 2002; 41 Suppl 1():7-11. PubMed ID: 12412346
[No Abstract] [Full Text] [Related]
17. Serum markers as prognostic factors in epithelial ovarian cancer: an overview.
Maggino T; Gadducci A
Eur J Gynaecol Oncol; 2000; 21(1):64-9. PubMed ID: 10726623
[TBL] [Abstract][Full Text] [Related]
18. Clinical decision making using ovarian cancer risk assessment.
Stany MP; Maxwell GL; Rose GS
AJR Am J Roentgenol; 2010 Feb; 194(2):337-42. PubMed ID: 20093593
[TBL] [Abstract][Full Text] [Related]
19. Massive oedema of the ovary--a tumour-like condition--report of two cases.
Jacob S; Prabhakar BR
Indian J Cancer; 1996 Dec; 33(4):181-2. PubMed ID: 9254996
[No Abstract] [Full Text] [Related]
20. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
